June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

March 7, 2017

Melanoma Gene Study May Help Predict Who Will Benefit from Immunotherapy

News

While high mutation load in metastatic melanoma is often associated with better responses to immune checkpoint inhibitors, researchers have found that loss of certain genomic regions in metastatic melanoma can bring ... Read more

March 2, 2017

Novel Microscopy Technique May Help Diagnose Elusive Melanomas Early

News

Mapping the distribution and quantity of melanin pigments in the skin can help doctors diagnose melanoma early, but pheomelanin — the pigment responsible for both the orange-reddishness in hair and a higher ... Read more

February 28, 2017

Gut Bacteria Composition May Determine Melanoma Patients’ Response to Anti-PD-1 Immunotherapy

News

The presence of a specific bacteria in the gut of patients with melanoma, as well as a greater diversity of gut bacteria, are associated with a better response to anti-PD-1 ... Read more

February 23, 2017

Study IDs Mechanism Underlying Metastatic Behavior in Melanoma Cells

News

Researchers have identified a cellular pathway that regulates the ability of melanoma cells to migrate to other parts of the body. This newly discovered mechanism may lead to the development of new targeted ... Read more

February 21, 2017

Results of Mole Mapper Mobile-app-based Skin Cancer Study Are in

News

The Mole Mapper Melanoma Study asked people to take photos of and measure their moles to determine their melanoma risk and advance skin cancer research. Now the results of the ... Read more

February 16, 2017

Melanoma Recurrence More Often Detected by Patients’ Self-checks Than Routine Imaging

News

Patients more often detect the recurrence of early stage melanoma by self-checks than physicians do by routine imaging tests, research shows. The study, “Patient Symptoms Are the Most Frequent Indicators ... Read more

February 14, 2017

NIH Researchers Reveal How Lack of Oxygen Helps Spread Melanoma

News

Researchers have gained further insight into how the lack of oxygen, or hypoxia, contributes to the progression of melanoma, identifying hypoxia-regulated genes that could direct melanoma diagnosis and treatment. Their findings ... Read more

February 9, 2017February 9, 2017

Keytruda Benefits Patients with Rare Mucosal Melanoma, Trials Show

News

Updates from clinical trials of Keytruda (pembrolizumab) for melanoma show that besides its known benefits for people with typical melanoma, the treatment is also effective against mucosal melanoma — a rare ... Read more

February 7, 2017

Melanoma Death Rates Will Fall by 2050, Study Says

News

The percentage of people who die of malignant melanoma is expected to decrease by 2050, even though the total number of deaths will likely rise due to population aging, according ... Read more

February 2, 2017

Melanoma Cells’ Skin Neighbors Can Stoke Tumor Expansion, Study Shows

News

A type of skin cell that is interspersed with the skin cells from which malignant melanoma arises can promote melanoma tumor expansion, a study says. Melanoma-related skin cells are called ... Read more

January 31, 2017

Castle’s Genetic Test, in Combo with AJCC’s Online Tool, Helped Identify High-Risk Melanomas

News

Results from a study assessing risk prediction using DecisionDx-Melanoma have shown that the gene test can significantly improve the identification of Stage 1 and 2 melanoma in patients at high-risk ... Read more

January 26, 2017

Deep Learning Algorithm Might Change How Skin Cancer Is Diagnosed

News

A team of Stanford scientists are developing an artificially intelligent (AI) diagnosis algorithm for skin cancer that might change the way medicine operates. The algorithm has so far been “trained” to ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group